Abstract
A series of chromone derivatives were designed as potential topoisomerase I (Top I) inhibitors based on the docking simulation study. Sixteen synthesized compounds were evaluated for Top I inhibitory activity and some compounds were further tested for in vitro cytotoxic activity. The most potent inhibitor, chromone 11b showed greater inhibitory activity (IC50 = 1.46 μM) than the known Top I inhibitors, i.e., camptothecin, fisetin and morin, but inactive against breast cancer cell (MCF-7), oral cavity cancer cell (KB) and small cell lung cancer (NCI-H187). Chromone 11c, another potent inhibitor (IC50 = 6.16 μM), exhibited cytotoxic activity against KB (IC 50 = 73.32 μM) and NCI-H187 (IC50 = 36.79 μM).
| Original language | English |
|---|---|
| Pages (from-to) | 329-339 |
| Number of pages | 11 |
| Journal | Medicinal Chemistry |
| Volume | 9 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - May 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Chromone derivatives
- Cytotoxic activity
- Topoisomerase i inhibitory activity
Fingerprint
Dive into the research topics of 'Synthesis, topoisomerase i inhibitory and cytotoxic activities of chromone derivatives'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver